Doxofylline

Small moleculeexperimental

Doxofylline is a phosphodiesterase inhibiting bronchodilator used in the treatment of chronic respiratory diseases such as asthma and COPD. Like theophylline, it is a xanthine derivative. — Wikipedia

Clinical trial activity

4 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
2

Earliest trial started Dec 1, 2008 (NCT01055041)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    Unclear

Chemistry & pharmacology

Loading structure…

SMILES

Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O
Mol. weight
266.26 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 1h-purine-2,6-dione, 7-(1,3-dioxolan-2-ylmethyl)-3,7-dihydro-1,3-dimethyl-
  • 2-(7'-theophyllinemethyl)1,3-dioxolane
  • ansimar
  • dioxyfilline
  • doxofylline
  • doxofylline
  • doxofylline
  • doxofylline
  • doxofylline
  • doxofylline
  • doxofylline
  • doxophylline
  • doxophylline
  • doxophylline
  • doxophylline
  • doxophylline
  • tmdo

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04238221Phase 4Mar 1, 2020University of Milan
NCT03879590Phase 3May 31, 2019Universidad Autonoma de Nuevo Leon
NCT03388853Phase 4Jan 31, 2018NeuTec Pharma
NCT01055041N/ADec 1, 2008Government Medical College, Bhavnagar, Sir T. General Hospital and Government Medical College
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government Medical College, BhavnagarAcademic/Hospital1112008
NeuTec PharmaFor profit1112018
Sir T. General Hospital and Government Medical CollegeAcademic/Hospital1012008
Universidad Autonoma de Nuevo LeonAcademic/Hospital1112019
University of MilanAcademic/Hospital1112020
5 organizations
Page 1 / 1